Eli Lilly and Company's office in Belgium: Markiesstraat B Brussels
Business Address: Markiesstraat 1 - 4B 1000 Brussels
Phone: +32(0)2 548 84 84, (0)2 548 84 94
Fax: 32 (0)2 548 84 85
E-mail: orders.benelux@lilly.com , be.medinfo@lilly.com, Safety_bemail-drug@lilly.com
Web: https://www.lilly.be
| Type | Public |
|---|---|
| Traded as |
|
| ISIN | |
| Industry | Pharmaceutical |
| Founded | 1876 (1876) |
| Founder | Eli Lilly |
| Headquarters | Indianapolis, Indiana, U.S. |
| Key people | David A. Ricks (Chairperson, President, & CEO) Anat Ashkenazi (Vice president & CFO) |
| Products | Pharmaceutical drugs |
| Revenue |  US$22.319 billion (2019) |
| Operating income | US$5.595 billion (2019) |
| Net income | US$8.318 billion (2019) |
| Total assets |  US$39.286 billion (2019) |
| Total equity | US$2.699 billion (2019) |
| Owner | Lilly Endowment, 11.6% |
| Number of employees | 33,625 (2019) |
| Website | www.lilly.com |
Lilly was founded in 1876 by Colonel Eli Lilly, a man committed to creating high-quality medicines that met real needs in an era of unreliable elixirs peddled by questionable characters. His charge to the generations of employees who have followed was this: "Take what you find here and make it better and better." More than 140 years later, we remain committed to his vision through every aspect of our business and the people we serve starting with those who take our medicines, and extending to health care professionals, employees and the communities in which we live.